On November 3, our co-founder Tom Whitehead participated in The Atlantic's fifth annal People v. Cancer Summit in New York City. He was joined by Dr. Bruce Levine of the University of Pennsylvania for a discussion on CAR T-cell therapy and the prospect of personalized mRNA cancer vaccines as new and promising cancer treatments.

The session was moderated by Dr. James Hamblin of Yale School of Public Health.

Watch the conversation here: